Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 476

1.

Urinary biomarkers to assess exposure of cats to environmental tobacco smoke.

McNiel EA, Carmella SG, Heath LA, Bliss RL, Le KA, Hecht SS.

Am J Vet Res. 2007 Apr;68(4):349-53.

PMID:
17397288
2.

Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.

Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16.

3.

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke.

Hecht SS, Carmella SG, Le KA, Murphy SE, Boettcher AJ, Le C, Koopmeiners J, An L, Hennrikus DJ.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):988-92.

4.

Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.

Stepanov I, Hecht SS, Duca G, Mardari I.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):7-11.

5.

Children's exposure to environmental tobacco smoke: using diverse exposure metrics to document ethnic/racial differences.

Sexton K, Adgate JL, Church TR, Hecht SS, Ramachandran G, Greaves IA, Fredrickson AL, Ryan AD, Carmella SG, Geisser MS.

Environ Health Perspect. 2004 Mar;112(3):392-7.

6.

Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.

Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1283-6.

7.

Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.

Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.

J Natl Cancer Inst. 2001 Mar 7;93(5):378-81.

8.

A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.

Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1617-23.

9.

Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.

Carmella SG, Borukhova A, Akerkar SA, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):113-20.

10.

Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP Jr.

Cancer. 2005 Apr 1;103(7):1420-6.

11.

[Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].

Florek E, Piekoszewski W, Lechowicz W, Szymańska A, Kornacka MK.

Przegl Lek. 2006;63(10):926-31. Polish.

PMID:
17288186
12.

Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.

Stepanov I, Hecht SS, Lindgren B, Jacob P 3rd, Wilson M, Benowitz NL.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1382-6.

13.

Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.

Vardavas CI, Fthenou E, Patelarou E, Bagkeris E, Murphy S, Hecht SS, Connolly GN, Chatzi L, Kogevinas M.

Tob Control. 2013 May;22(3):194-200. doi: 10.1136/tobaccocontrol-2011-050144. Epub 2012 Jan 17.

PMID:
22253001
14.

Metabolites of a tobacco-specific carcinogen in urine from newborns.

Lackmann GM, Salzberger U, Töllner U, Chen M, Carmella SG, Hecht SS.

J Natl Cancer Inst. 1999 Mar 3;91(5):459-65.

15.

Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.

Florek E, Piekoszewski W, Basior A, Merritt AT, Mazela J, Lechowicz W, Kornacka MK, Kramer L.

J Physiol Pharmacol. 2011 Jun;62(3):377-83.

16.

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.

Cancer Res. 1999 Feb 1;59(3):590-6.

17.

The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.

Vogel RI, Carmella SG, Stepanov I, Hatsukami DK, Hecht SS.

Biomarkers. 2011 Sep;16(6):491-7. doi: 10.3109/1354750X.2011.598565. Epub 2011 Aug 3.

18.

Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.

Hu CW, Hsu YW, Chen JL, Tam LM, Chao MR.

Arch Toxicol. 2014 Feb;88(2):291-9. doi: 10.1007/s00204-013-1137-y. Epub 2013 Sep 22.

PMID:
24057573
19.

Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.

Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2963-8.

20.

Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.

Melikian AA, Djordjevic MV, Chen S, Richie J Jr, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1408-15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk